Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical recombinant lysostaphin for MRSA-infected deep partial-thickness burn wounds
CTR20150550Phase 2Completed
- Sponsor
- Shanghai Gaoke United Biotechnology Research and Development
- Start
- Aug 2015
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of staphylolysin in methicillin-resistant Staphylococcus aureus burn wound infection, burn wound infection, sponsored by Shanghai Gaoke United Biotechnology Research and Development. Started Aug 2015; status: completed.
02
Drugs
staphylolysin
03
Conditions
methicillin-resistant Staphylococcus aureus burn wound infectionburn wound infection
Beyond the preview
Go deeper on CTR20150550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150550.